Skip to main content
Log in

Solid organ transplantation is a reality for patients with HIV infection

  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

Abstract

Recent policies, guidelines, and laws reflect promising preliminary outcomes among transplant recipients with HIV infection, and ethical analyses suggest that it is not justifiable to deny solid organ transplantation based solely on HIV-infection status. These studies consistently describe stable HIV disease following liver and kidney transplantation. Despite good graft survival, kidney allograft rejection occurs frequently, and serious non-AIDS-defining infections requiring hospitalization are common following antirejection therapy. Profound interactions between immunosuppressants and antiretroviral drugs require careful monitoring, dose adjustment, and highly effective communication between the patient and a multidisciplinary group of health care providers. Despite these scientific and policy advances, many health care providers and patients remain unaware of ongoing progress in this field. The implications are critical, as late referral for liver transplant evaluation increases the pretransplant mortality risk. Because important patient selection and clinical management questions remain, it is critical that ongoing studies are completed quickly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Puoti M, Bruno R, Soriano V, et al.: Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS 2004, 18:2285–2293.

    Article  PubMed  Google Scholar 

  2. Rosenthal E, Poiree M, Pradier C, et al.: Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 2003, 17:1803–1809.

    Article  PubMed  Google Scholar 

  3. Mocroft A, Soriano V, Rockstroh J, et al.: Is there evidence for an increase in the death rate from liver-related disease in patients with HIV? AIDS 2005, 19:2117–2125.

    Article  PubMed  Google Scholar 

  4. Ragni MV, Eghtesad B, Schlesinger KW, et al.: Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl 2005, 11:1425–1430.

    Article  PubMed  Google Scholar 

  5. Thio CL, Seaberg EC, Skolasky R Jr, et al.: HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002, 360:1921–1926.

    Article  PubMed  Google Scholar 

  6. Stock PG: Rapid deterioration of HIV co-infected patients waiting for liver transplantation is not predicted by MELD. Liver Transpl 2005, 11:1315–1317.

    Article  PubMed  Google Scholar 

  7. Palella FJ Jr, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998, 338:853–860.

    Article  PubMed  Google Scholar 

  8. Halpern SD, Ubel PA, Caplan AL: Solid-organ transplantation in HIV-infected patients. N Engl J Med 2002, 347:284–287.

    Article  PubMed  Google Scholar 

  9. Roland ME, Havlir DV: Responding to organ failure in HIV-infected patients. N Engl J Med 2003, 348:2279–2281.

    Article  PubMed  Google Scholar 

  10. Roland ME, Lo B, Braff J, Stock PG: Key clinical, ethical, and policy ssues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients. Arch Intern Med 2003, 163:1773–1778.

    Article  PubMed  Google Scholar 

  11. Miro JM, Torre-Cisnero J, Moreno A, et al.: GESIDA/ GESITRA-SEIMC, SPNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patient in Spain 2005. Enferm Infecc Microbiol Clin 2005, 23:353–362.

    Article  PubMed  Google Scholar 

  12. O‘Grady J, Taylor C, Brook G: Guidelines for liver transplantation in patients with HIV infection (2005). HIV Med 2005, 6(Suppl 2):149–153.

    Article  PubMed  Google Scholar 

  13. Tien PC: Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office. Am J Gastroenterol 2005, 100:2338–2354.

    Article  PubMed  Google Scholar 

  14. Stock PG, Roland ME, Carlson L, et al.: Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation 2003, 76:370–375.

    Article  PubMed  Google Scholar 

  15. Roland ME, Adey D, Carlson LL, Terrault NA: Kidney and liver transplantation in HIV-infected patients: case presentations and review. AIDS Patient Care STDS 2003, 17:501–507.

    Article  PubMed  Google Scholar 

  16. Roland ME, Stock PG: Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003, 75:425–429. ains combined retrospective and prospective multisite data on 45 liver and kidney transplant recipients with HIV infection, suggesting similar patient and graft survival outcomes as the general transplant population

    Article  PubMed  Google Scholar 

  17. Ragni MV, Belle SH, Im K, et al.: Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 2003, 188:1412–1420. ticenter analysis of liver transplant recipients with HIV infection again suggests that survival is similar in this group compared with the general transplant population. Hepatitis C is associated with poorer survival, and there is a trend towards worse survival in the HIV-HCV co-infected group compared with HCV monoinfected patients

    Article  PubMed  Google Scholar 

  18. Abbott KC, Swanson SJ, Agodoa LY, Kimmel PL: Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression. J Am Soc Nephrol 2004, 15:1633–1639. ospective analysis of 47 kidney transplant recipients with HIV infection in a large database, demonstrating excellent patient and graft survival

    Article  PubMed  Google Scholar 

  19. Kumar MS, Sierka DR, Damask AM, et al.: Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. Kidney Int 2005, 67:1622–1629. spective study of 40 kidney transplant recipients at Drexel University. Outcomes are good but not as good as in the study by Abbott et al. [18]

    Article  PubMed  Google Scholar 

  20. Vogel M, Voigt E, Schafer N, et al.: Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: outcome of 7 patients from the Bonn cohort. Liver Transpl 2005, 11:1515–1521.

    Article  PubMed  Google Scholar 

  21. Carter JT, Melcher ML, Carlson LL, et al.: Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients. Am J Transplant 2006, 6:753–760. ograft rejection is more common in transplant recipients with HIV infection than in the general transplant population. Kidney transplant recipients who received thymoglobulin were at increased risk for serious non-AIDS-defining infections that required hospitalization

    Article  PubMed  CAS  Google Scholar 

  22. Frassetto L, Baluom M, Jacobsen W, et al.: Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients. Transplantation 2005, 80:13–17. losporine doses must be reduced significantly when used with protease-inhibitor-containing antiretroviral regimens

    Article  PubMed  CAS  Google Scholar 

  23. Toso C, Berney T, Oberholzer J, et al.: Kidney-pancreas transplantation in a long-term non-progressor HIV-infected recipient. Am J Transplant 2003, 3:631–633.

    Article  PubMed  Google Scholar 

  24. Tan HP, Kaczorowski DJ, Basu A, et al.: Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. Transplantation 2004, 78:1683–1688.

    Article  PubMed  CAS  Google Scholar 

  25. Norris S, Taylor C, Muiesan P, et al.: Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl 2004, 10:1271–1278.

    Article  PubMed  Google Scholar 

  26. Moreno S, Fortun J, Quereda C, et al.: Liver transplantation in HIV-infected recipients. Liver Transpl 2005, 11:76–81.

    Article  PubMed  Google Scholar 

  27. Rafecas A, Rufi G, Figueras J, et al.: Liver transplantation without steroid induction in HIV-infected patients. Liver Transpl 2004, 10:1320–1323.

    Article  PubMed  Google Scholar 

  28. Radecke K, Fruhauf NR, Miller M, et al.: Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis. Liver Int 2005, 25:101–108.

    Article  PubMed  Google Scholar 

  29. Honkoop P, Kazemier G, Perenboom RM, et al.: [Liver transplantation in a HIV-positive patient receiving potent antiretroviral therapy; the first case in The Netherlands]. Ned Tijdschr Geneeskd 2004, 148:2500 -2504.

    PubMed  CAS  Google Scholar 

  30. Terrault NA CJ, Carlson L, Roland M, Stock P. come of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transpl, In press.

  31. Dave MB, Shabih K, Blum S: Maintenance hemodialysis in patients with HIV-associated nephropathy. Clin Nephrol 1998, 50:367–374.

    PubMed  CAS  Google Scholar 

  32. Perinbasekar S, Brod-Miller C, Pal S, Mattana J: Predictors of survival in HIV-infected patients on hemodialysis. Am J Nephrol 1996, 16:280 -286.

    PubMed  CAS  Google Scholar 

  33. Schoenfeld P, Mendelson M, Rodriguez R: Survival of ESRD patients with HIV infection. J Am Soc Nephrol 1995, 6:561.

    Google Scholar 

  34. Jain A, Venkataramanan R, Shapiro R, et al.: The interaction between anti-retroviral agents and tacrolimus in liver and kidney transplant patients. Paper presented at the American Transplant Congress. Washington, DC; April 26–May 1, 2002.

  35. Guaraldi G, Cocchi S, Codeluppi M, et al.: Role of therapeutic drug monitoring in a patient with human immunodeficiency virus infection and end-stage liver disease undergoing orthotopic liver transplantation. Transplant Proc 2005, 37:2609–2610.

    Article  PubMed  CAS  Google Scholar 

  36. Vogel M, Voigt E, Michaelis HC, et al.: Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in livertransplanted HIV-infected patients. Liver Transpl 2004, 10:939–944.

    Article  PubMed  Google Scholar 

  37. Chapuis AG, Paolo Rizzardi G, D‘Agostino C, et al.: Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nat Med 2000, 6:762–768.

    Article  PubMed  CAS  Google Scholar 

  38. Margolis DM, Kewn S, Coull JJ, et al.: The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNA. J Acquir Immune Defic Syndr 2002, 31:45–49.

    PubMed  CAS  Google Scholar 

  39. Hossain MM, Coull JJ, Drusano GL, Margolis DM: Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir. Antiviral Res 2002, 55:41–52.

    Article  PubMed  CAS  Google Scholar 

  40. Dummer JS, Erb S, Breinig MK, et al.: Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981–1986. Transplantation 1989, 47:134 -140.

    Article  PubMed  CAS  Google Scholar 

  41. Poli F, Scalamogna M, Pizzi C, et al.: HIV infection in cadaveric renal allograft recipients in the North Italy Transplant Program. Transplantation 1989, 47:724 -725.

    Article  PubMed  CAS  Google Scholar 

  42. Tzakis AG, Cooper MH, Dummer JS, et al.: Transplantation in HIV+ patients. Transplantation 1990, 49:354 -358.

    Article  PubMed  CAS  Google Scholar 

  43. Erice A, Rhame FS, Heussner RC, et al.: Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. Rev Infect Dis 1991, 13:537–547.

    PubMed  CAS  Google Scholar 

  44. Bouscarat F, Samuel D, Simon F, et al.: An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis 1994, 19:854–859.

    PubMed  CAS  Google Scholar 

  45. Ahuja TS, Zingman B, Glicklich D: Long-term survival in an HIV-infected renal transplant recipient. Am J Nephrol 1997, 17:480–482.

    Article  PubMed  CAS  Google Scholar 

  46. Ragni MV, Bontempo FA, Lewis JH: Organ transplantation in HIV-positive patients with hemophilia [letter]. N Engl J Med 1990, 322:1886–1887.

    PubMed  CAS  Google Scholar 

  47. Calabrese LH, Albrecht M, Young J, et al.: Successful cardiac transplantation in an HIV-1-infected patient with advanced disease. N Engl J Med 2003, 348:2323–2328.

    Article  PubMed  Google Scholar 

  48. Vogel M, Voigt E, Wasmuth JC, Brackmann et al.: Orthotopic liver transplantation in HIV-positive patients: outcome of 10 patients from the Bonn cohort. Paper presented at the 12th Conference on Retroviruses and Opportunistic Infections. Boston, MA; February 22–25, 2005.

  49. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA). MMWR Recomm Rep 1999, 48:1–59, 61–66.

  50. Palefsky JH, Holly EA. Efirdc JT, et al.: Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005, 19:1407–1414.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michelle E. Roland MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roland, M.E., Stock, P.G. Solid organ transplantation is a reality for patients with HIV infection. Curr HIV/AIDS Rep 3, 132–138 (2006). https://doi.org/10.1007/BF02696657

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02696657

Keywords

Navigation